Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biolosion + Immunotherapy in Advanced Urothelial Carcinoma
NCT06904573Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
A Phase 2 trial of Biolosion in urothelial carcinoma (UC), sponsored by Sun Yat-sen University. Started Jan 2025; status: recruiting.
02
Drugs
Biolosion
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT06904573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06904573.